Results of the Study Published in the Journal of Urology IRVINE, CA, and LIEGE, BELGIUM - February 11, 2013 - MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to support the …
